YDES (YD Bio) Notes Receivable: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YDES YD Bio Ltd YDES
12 GF Score
Price $2.15
! 1 Warning Sign
View Full Analysis

What is YD Bio Notes Receivable?

YD Bio YDES -3.59% 12 Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

YD Bio's Notes Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.

YD Bio Notes Receivable Historical Data

* Premium members only.

The historical data trend for YD Bio's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YD Bio Notes Receivable Chart

YD Bio Annual Data
Trend Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00

YD Bio Semi-Annual Data
Dec24 Jun25 Dec25
Notes Receivable 0.00 0.00 0.00
YDES
12GF Score
YD Bio Ltd YDES
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

YD Bio Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
YD Bio (YDES) has a Notes Receivable of $0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on YD Bio and its competitors.
Is YD Bio's Notes Receivable too high?
YD Bio's current Notes Receivable is $0.00 Mil. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's Notes Receivable compare to CRBU and ABOS?
YD Bio's Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on YD Bio and its competitors. YD Bio's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For YD Bio (YDES), the current Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

YD Bio Business Description

Address No. 3, Xingnan Street, 12th Floor, Nangang District, Taipei City, TWN, 115001
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score

Get the complete analysis for YDES

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price